Bristol Myers Squibb Co. Stock Rises Monday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.58% higher to $68.07 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.16% to 3,977.53 and the Dow Jones Industrial Average rising 0.60% to 32,432.08. This was the stock's second consecutive day of gains. Bristol Myers Squibb Co. closed $13.37 below its 52-week high ($81.44), which the company reached on December 1st.
The stock outperformed some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.43% to $153.30, Pfizer Inc. (PFE) fell 0.42% to $40.22, and Abbott Laboratories (ABT) rose 0.42% to $98.46. Trading volume (6.7 M) remained 1.6 million below its 50-day average volume of 8.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 27, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 27, 2023 16:41 ET (20:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.